The 2025 Cancer Summit brings together leaders in healthcare, oncology and benefits management to discuss the latest advancements in cancer care and how employers can best support employees facing a cancer diagnosis. This one-day event focuses on the intersection of innovative cancer treatments and benefits design, caregiving, and providing employers with strategies to improve employee outcomes while managing the rising healthcare costs.
The 2025 Cancer Summit brings together leaders in healthcare, oncology and benefits management to discuss the latest advancements in cancer care and how employers can best support employees facing a cancer diagnosis. This one-day event focuses on the intersection of innovative cancer treatments and benefits design, caregiving, and providing employers with strategies to improve employee outcomes while managing the rising healthcare costs.
The doctors are in!
Dive into hot health topics with the experts and hear what you might need to do for your employees.
Every other Monday at 1 PM – it’s prescription viewing!
Men are less likely to seek preventive care or undergo cancer screenings—putting them at higher risk for serious illness and premature death. These gaps have implications for employers, driving higher healthcare costs, absenteeism, and avoidable claims.
Join the NEBGH/MSK Direct fireside chat with Dr. Robert Sidlow from Memorial Sloan Kettering Cancer Center (MSK) for a practical discussion on men’s health and cancer screening. Learn what’s driving these disparities, the latest in cancer screening for men, and how employers can take action to support early detection and better outcomes.
Empathy, Inclusion and Fairness as Essential Ingredients for a Mentally Healthy Workforce
Does clinical subspecialty expertise have an impact on patient outcomes? What role do expert medical opinions play in ensuring the optimal treatment plan?
Hear about:
….. and more!
Delivering the best possible mental health care with measurement-based care.
We’ll tackle high-cost pipeline drugs, precision medicine, PBM strategies, cost and transparency regulation, pharmaco-equity, GLP-1 Agonists … and more. Be there!